OpenScience.ink

Hot New Top

3 weeks ago • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

How well combined treatments work for people with chronic kidney disease and type 2 diabetes using real-world dataComparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.

🎖️ Top 10% JournalArticle

3 weeks ago • The lancet. Diabetes & endocrinology

How Body Fat Links to Multiple Health Problems and Why Weight Loss May HelpFrom adiposity to multisystem morbidity: the case for weight loss as disease modification.

🥇 Top 1% JournalArticle

3 weeks ago • The Journal of clinical endocrinology and metabolism

Semaglutide versus Weight-Loss Surgery on Noninvasive Signs of Liver Fat and Scarring in Obesity with MASLDEffects of Semaglutide versus Bariatric Surgery on Noninvasive Markers of Hepatic Steatosis and Fibrosis in Obesity with MASLD.

🥉 Top 5% JournalArticle

3 weeks ago • Obesity pillars

Use of GLP-1 and GLP-1/GIP Medicines and Their Reported Effects in People with Lipedema from a Large Online SurveyGLP-1 and GLP-1/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey.

📖 Top 20% JournalArticle

3 weeks ago • Trends in pharmacological sciences

Identifying how GLP1R signaling favors different pathwaysDe-Nterm-ining GLP1R signaling bias.

🥈 Top 2% JournalArticle

3 weeks ago • Cardiovascular diabetology

Disease-changing diabetes drugs: linking the SIMPLE method to stopping disease earlyDisease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception.

🥈 Top 2% JournalArticle

3 weeks ago • Current oncology reports

What We Know About Weight-Loss Drugs Acting on GLP-1 Receptors and Their Link to Obesity-Related CancersGLP-1 Receptor Agonists and Obesity Related Cancers: What We Know So Far.

🎖️ Top 10% JournalArticle

3 weeks ago • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

GLP-1 receptor drugs linked to lower kidney cancer risk after weight-loss surgeryGLP-1 receptor agonists are associated with lower kidney cancer risk after metabolic bariatric surgery.

🎖️ Top 10% JournalArticle

3 weeks ago • Cardiovascular diabetology

Genetic links between hormone receptor pathways and healthier aging traitsGenetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study.

🥈 Top 2% JournalArticle

3 weeks ago • Obesity (Silver Spring, Md.)

Effectiveness and Safety of GLP-1 Medicines for Patients Who Regain Weight After Weight-Loss SurgeryReal-World Effectiveness and Safety of GLP-1 Receptor Agonists Among Patients With Weight Recurrence After Bariatric Surgery.

🎖️ Top 10% JournalArticle

3 weeks ago • Obesity pillars

One-year weight loss and metabolism changes after sleeve stomach surgery in teens compared with young adultsOne-year weight loss and metabolic outcomes after laparoscopic sleeve gastrectomy in adolescents compared with young adults: A propensity score-matched cohort study.

📖 Top 20% JournalArticle

3 weeks ago • Food & function

Non-digestible stachyose may reverse insulin resistance caused by overeating by boosting a hormone that regulates blood sugarNon-digestible stachyose reverses overnutrition-induced insulin resistance via stimulating the secretion of glucagon-like peptide-1.

📖 Top 20% JournalArticle

3 weeks ago • International journal of women's dermatology

Medical weight management’s effects on appearance, muscle, and skin based on patient reports to guide overall preventionAesthetic, muscle, and dermatologic effects of medical weight management: patient-reported outcomes shape a holistic preventive procedural approach.

📖 Top 30% JournalArticle

3 weeks ago • Obesity facts

Changes in Body Fat, Metabolism, and Muscle Strength Over Time in People with Obesity Taking SemaglutideLongitudinal Changes in Body Composition, Adaptive Thermogenesis and Muscle Strength in Patients with Obesity Treated with Semaglutide.

🎖️ Top 10% JournalArticle

3 weeks ago • RMD open

Metabolic changes and inflammation in rheumatology patients treated with GLP-1 receptor drugsMetabolic effects of GLP-1 receptor agonists in rheumatology patients and inflammatory outcomes: a single-centre retrospective cohort.

🎖️ Top 10% JournalArticle

3 weeks ago • BMJ open

Effectiveness and safety of diabetes drugs that activate GLP-1 receptors for heart muscle disease in diabetesEfficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis.

📖 Top 20% JournalArticle

3 weeks ago • Clinical journal of the American Society of Nephrology : CJASN

Use of Glucagon-Like Peptide-1 Drugs and Risks of Hospital Stay and Death in People with Advanced Kidney DiseaseGlucagon-Like Peptide-1 Receptor Agonist Use and Risks of Hospitalization and Mortality in Patients with End-Stage Kidney Disease.

🥉 Top 5% JournalArticle

3 weeks ago • Food research international (Ottawa, Ont.)

Core-shell hydrogel beads carrying trypsin inhibitor for better stability of oral active peptidesCore-shell hydrogel beads co-encapsulating kunitz-type trypsin inhibitor: A synergistic strategy for enhanced stability of oral active peptides.

🎖️ Top 10% JournalArticle

3 weeks ago • Journal of endocrinological investigation

How a specific RNA modification controls GLP-1 hormone release through a protein pathway in type 2 diabetic miceMettl14-mediated m6A modification of lncRNA Gm2824 regulates GLP-1 secretion via the YBX1/Foxa1 pathway in type 2 diabetic mice.

📖 Top 20% JournalArticle

3 weeks ago • Journal of diabetes investigation

Glucagon-like peptide-1 drugs linked to poor bowel cleaning before colonoscopy in people with diabetesUse of glucagon-like peptide-1 receptor agonists is associated with inadequate bowel preparation for colonoscopy in patients with diabetes.

📖 Top 20% JournalArticle

3 weeks ago • European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

GLP-1 receptor agonists and recovery results after neck spine fusion surgery: a review and analysis of real-world dataGLP-1 receptor agonists and outcomes after cervical spine fusion: a systematic review, meta-analysis, and evidence map of real-world evidence.

📖 Top 20% JournalArticle

3 weeks ago • Bioscience trends

How GLP-1 receptor drugs may change immune and metabolism functions in people with HIVImmunometabolic reprogramming via GLP-1 receptor agonists in people with HIV: A multidimensional systemic framework.

📖 Top 20% JournalArticle

4 weeks ago • iScience

Comparing semaglutide, tirzepatide, and retatrutide on kidney scarring in blocked and old miceComparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.

🎖️ Top 10% JournalArticle

4 weeks ago • Advances in therapy

How Blood Sugar Treatments Relate to Memory and Thinking Loss: From Biological Processes to Patient Studies and Future DirectionsGlucose-Lowering Therapies and Cognitive Decline: From Molecular Mechanisms to Clinical Evidence and Future Perspectives.

📖 Top 20% JournalArticle

4 weeks ago • Appetite